Matches in Wikidata for { <http://www.wikidata.org/entity/Q82357642> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q82357642 description "article scientifique (publié 2010)" @default.
- Q82357642 description "articolo scientifico (pubblicato il 2010)" @default.
- Q82357642 description "artikull shkencor i botuar më 01 janar 2010" @default.
- Q82357642 description "artículu científicu espublizáu en xineru de 2010" @default.
- Q82357642 description "im Jahr 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82357642 description "scientific article published on 01 January 2010" @default.
- Q82357642 description "wetenschappelijk artikel" @default.
- Q82357642 description "наукова стаття, опублікована в січні 2010" @default.
- Q82357642 name "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 name "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 name "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 type Item @default.
- Q82357642 label "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 label "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 label "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 prefLabel "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 prefLabel "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 prefLabel "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy" @default.
- Q82357642 P1433 Q82357642-20F45402-DDE8-4072-B3F8-D18CC934C883 @default.
- Q82357642 P1476 Q82357642-08DF3389-978E-4F0C-816A-92DCD5AA347C @default.
- Q82357642 P2093 Q82357642-29C8C88A-2C09-4670-8245-18E1BCE9FB82 @default.
- Q82357642 P2093 Q82357642-7C3DE5AB-3A53-4074-BE83-C09370480B55 @default.
- Q82357642 P2093 Q82357642-87D0A7CF-7202-4D12-BFC8-307F842C744B @default.
- Q82357642 P2093 Q82357642-A0F714EA-5492-402A-B342-DB706933C222 @default.
- Q82357642 P304 Q82357642-16ECFBB1-0429-4CE2-A3ED-C3673B91A454 @default.
- Q82357642 P31 Q82357642-3274E49D-38BC-46DB-8025-3F78DB1AD71B @default.
- Q82357642 P356 Q82357642-B68C75A3-B73A-4C30-87F4-29BE90D668ED @default.
- Q82357642 P433 Q82357642-4FEA1CA2-E5A1-42EB-AA66-86DCDB3A4532 @default.
- Q82357642 P478 Q82357642-FC6F44A8-9B22-49C4-8136-48BD372B854A @default.
- Q82357642 P577 Q82357642-4110BC1E-5CDC-4E22-BA42-403882DDDB3E @default.
- Q82357642 P698 Q82357642-900851A7-5E57-4A15-AB7F-AD01EB6A5DB1 @default.
- Q82357642 P921 Q82357642-0096CF38-DB7C-474B-A1A0-B60C2A75AFBB @default.
- Q82357642 P921 Q82357642-3A13DD30-7288-424F-A094-24656C159F5E @default.
- Q82357642 P921 Q82357642-749470CE-92BB-44BF-B4A8-91F340E03907 @default.
- Q82357642 P356 ART.25053 @default.
- Q82357642 P698 20039425 @default.
- Q82357642 P1433 Q23929027 @default.
- Q82357642 P1476 "Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone" @default.
- Q82357642 P2093 "Elizabeth Thompson" @default.
- Q82357642 P2093 "Josef S Smolen" @default.
- Q82357642 P2093 "Patrick Garnero" @default.
- Q82357642 P2093 "Thasia Woodworth" @default.
- Q82357642 P304 "33-43" @default.
- Q82357642 P31 Q13442814 @default.
- Q82357642 P356 "10.1002/ART.25053" @default.
- Q82357642 P433 "1" @default.
- Q82357642 P478 "62" @default.
- Q82357642 P577 "2010-01-01T00:00:00Z" @default.
- Q82357642 P698 "20039425" @default.
- Q82357642 P921 Q187255 @default.
- Q82357642 P921 Q422232 @default.
- Q82357642 P921 Q425154 @default.